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1133-153 Relationship Between Serum Cholesterol Levels and 
Development of Arterial Hypertension in the Population 
of the Brisighella Heart Study 
Claudia Borghi, Ada Dormi, Antonio Gaddi, Ettore Ambrosioini, St. Orsola-Malpighi 
Hospital, Bologna. Italy 
Background. Hypertension (HTN) and high serum cholesterol (HC) level are often com- 
bined in the same subject where they contribute to the overall cardiovascular risk proflle. 
HC is associated with a” impaired vasodilatory capacity and a” overexpression of vascu- 
lar angiotensin II receptors, which can contribute to the develpment of HTN. Aim of the 
present study was to investigate the role of HC, if any, in the development of HTN in the 
Brisighella Heart Study. 
Methods. 1230 “ormotensive subjects (SBP/DBPcl40/90 mmHg) enrolled in the Bri- 
slghella Heart Study in 1972 have been divided according to total serum cholesterol (T- 
Chol) tertiles and followed for 12 years to evaluate the proportion of patients developing 
HTN defined as SBP and/or DBP>l40/90 mmHg and/or therapy for HTN. 
Results. After adjustment for the main counfondlng factors (family history of HTN, age, 
BMI, sex, diabetes) the rate of HTN was significantly increased in subjects with T-Chol z 
239 mg/dl both after 8 (1980) and 12 (1984) years of follow-up (‘p<O.OOi YS. other sub- 
groups). The rate of development of HTN was enhanced in the two older subgroups of 
subjects (30-59 and z-59 years). 
Conclusion. These data suggest that HC could substantially contribute to the develop- 
ment of HTN and strongly support the wide role of lipid lowering drugs and particulary 
statins in the pnmary prevention of cardiovascular disease. 
T-Chol < 200 mgldl 
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1133-154 Chronic Inflammation Adds to Metabolic Syndrome in 
the Prediction of Microalbuminuria 
Adrian W. Messerli, Gregory L. Pearce, Byron Hoogwerf, Dennis L. Sprecher, The 
Cleveland Clinic Foundation, Cleveland, OH 
Background: We have demonstrated that chronic inflammation, represented by c-reac- 
tive protein (CRP), predicts the presence of endothelial dysfunction, manifest as urinary 
albumin excretion. We hypothesize that the association of CRP with urine albumin is pre- 
dominately mediated through its correlation with the metabolic syndrome. Methods: 
Serum CRP and urine albumi”:creatinlne ratios (ACR) from 784 patients were analyzed 
to estimate age and gender adjusted relative risk of high CRP and metabolic syndrome 
for high ACR. High ACR was defined as >14.4 units (approximating the upper quartlIes of 
the HOPE trial) and high CRP was defined >0.20 mg/dL. Metabolic syndrome is defined 
per ATP Ill guidelines. Results: High ACR rates were 11% (301275) when neither high 
CRP “or metabolic syndrome were present, 23% (571243) when isolated high CRP was 
present, 23% (20187) when isolated metabolic syndrome was present and 35% (62079) 
when conjoint high CRP and metabohc syndrome were present. The odds ratio of 4.2 
when both factors were present was significantly higher than either isolated high CRP 
(p=O.Ol) or Isolated metabolic syndrome (p=O.OZ).(See table) Conclusion: The combined 
presence of elevated CRP and metabolic syndrome predicts a 4.fold increase in the 
occurence of elevated urinary albumin loss. This is consistent with both inflammation and 
traditional metabolic clinlcal risk negatively influencing endothelial function. 
Neither risk 
Isolated high CRP 
Isolated metabolic syndrome 
Conjoint high CRP and metabolic syndrome 
Odds Ratio (95% Cl) 
1 .o 
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2 l(l.1.3.9) 
4.2 (2.5-6.9) 
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828F0 Featured Oral Session...Natriuretic 
Peptides: What Are They Telling Us? 
Monday, March 31, 2003, 4:00 p.m.-5:30 p.m. 
McCormick Place, Room S105 
4:15 p.m. 
828FO-2 Plasma Neurohormones as Markers of Right Ventricular 
Overload and Predictors of Mortality in Acute 
Pulmonary Embolism 
laor I. Tulevski, Marye ten Wolde, Jasper W. M. Mulder. Dirk J. van Veldhuise”, Ernst E. 
van der Wall, Harry Buller, Barbara J M. Mulder, Academic Medical Center, Amsterdam, 
The Netherlands 
Background: Right ventricular (RV) function IS of major prognostic significance in 
patients with acute pulmonary embolism (PE). We studied the role of plasma neurohor- 
manes Brain Natrluretic Peptide (BNP) and Atrial Natriuretic Peptlde (ANP), and their 
potential to predict mortality in patients with acute PE. Methods: Plasma “eurohormone 
levels were measured in 114 patients (age 58(17) with acute PE within a” hour of pre- 
sent&ion after confirmed diagnosis by lung angiography and/or sclntigraphy. Twenty 
seven healthy age-matched volunteers served as controls (age 42(12)). Renal impalr- 
ment, atrial arrhythmias, preexisting RV pathology, and left ventricular dysfunction were 
exclusion criteria. In the patient group, survival was considered for a period of 30 
daysResults: Plasma BNP and ANP levels were significantly higher in patients with 
acute PE than in controls (BNP 34.4t61.9 pmol/L versus 3.1+3.7 pmoliL; p=O.Ol, and 
ANP 11.&17.3 pmol/L versus 4.6kl.9 pmollL; p=O.O3). Neurohormones were signifi- 
cantly higher in six patients who died within 30 days, compared to 108 patients who sur- 
vived (BNP 129.5*139.1 pmol/L versus 29.1*51.1 pmol/L; p=O.OOOl, and ANP 
34.lk53.9 pmol/L versus 10.6il2.3 pmol/L; p=O.OOl). 
Conclusions Neurohormone secretion is increased during acute PE in response to right 
ventricular overload. There was a significant relationship between presenting BNP and 
ANP levels, and 30.day mortality in patients with acute PE. Plasma “eurohormone levels 
may complement the diagnosis, treatment and in-hospital prognosis of patients with 
acute RV pressure overload such as see” in acute PE. 
4:30 p.m. 
828FO-3 Pro-Brain Natriuretic Peptide Predicts Severe 
Cardiovascular Events in Patients With Heart Disease 
Thomas Weber, Johann Auer. Elisabeth Lassnig, Marlina Strobl, Robert Berent, Bemd 
Eber, General Hospital of the Kreuzschwestern, Wels, Austria 
Background : The value of brain natrluretic peptide ( BNP ) in the diagnosis of heart fail- 
ure is well known. Moreover, BNP levels have prognostic significance after myocardial 
infarction and in heart failure. We tested the prognostic impact of BNP in a variety of dif- 
ferent heart diseases. 
Methods : We prospectively measured blood levels of n-terminal pro-BNP. using an 
immunoassay ( Elecsys pro BNP test, Roche diagnostics ), in patients undergoing car- 
diac catheterization in our laboratory for routine evaluation of heart disease. Follow-up 
data were collected at hospital discharge and after 3 months. 68 out of a total of 1730 
patients suffered from cardiovascular events ( event group ). As a control group served 
105 patients with a” uneventful course. Both groups were balanced with respect of age, 
sex, lipids, hypertension, diabetes, creatinine, smoking status, diagnosis, extent of coro- 
nary artery disease, left ventricular function, percutaneous interventions ( percentage, 
balloon and stent diameters, multivessel-interventions ) and medication use. For statis- 
tics we used Mann-Whitney U test and t-test, as appropriate. BNP values are given as 
mea” + / standard deviation. 
Results : The main diagnosis in both groups was coronary heart disease ( 79 vs 80 % ), 
fewer patients had valvular disease ( 15 vs 14 % ) or non-cardiac chest pain ( 6 % both 
groups ). Percutaneous interventions were performed in 45 (control group ) vs 50 (event 
group ) % of the patients. l&l patients had events during the first hospitalization ( includ- 
ing 12 myocardial Infarctions, 3 strokes and 5 deaths ), 50 patients had later events ( 
including 15 restenoses, 11 myocardial infarctions, 6 strokes and 23 deaths ). BNP-lev- 
els were higher in the event group than I” the control group ( 2958 + / - 7370 vs 1021 + / 
1591 pg/ml; p = 0,Ol ). BNP tended to be higher in patients with early events than with 
later events ( 5072 + ! - 11805 vs 2197 + i 4867 pg/ml, p = 0.16 ). In the event group. 
BNP was higher in patients who died than in patients with non-fatal complications ( 6017 
+/-11117vs1064+/-1947pg/ml,p=0,006). 
Conclusion : Pro-BNP is a” independent prognostic marker in a broad spectrum of 
patients with ischemic and valvular heart disease. 
4:45 p.m. 
828FO-4 What Causes Elevated B-Type Natriuretic Peptide in 
Patients Without Heart Failure? 
PeterA. McCullough, Philippe Gabriel Steg. Marie-Claude Aumont, Philippe Due, 
Torb~orn Omland. Catherine W. Knudsen, Richard M. Nowak, James McCord, Judd E. 
Hollander, Arne Westheim, Ala” 8. Storrow, William T. Abraham, Sumant Lamba, Alan 
H. Wu, Ala” S. Maisel, BNP MultInational Study Investigators, William Beaumont 
Hospltal, Royal Oak, MI, University of California, San Diego School of Medicine, 
Veterans Affairs Medical Center, San Diego, CA 
Introduction: Bedside plasma B-type “atriuretic peptide (BNP) can be used to reliably 
identify decompensatecf congestive heart failure (CHF) in patients presenting in the 
emergency department (ED) with acute dyspnea. Left ventricular (LV) systolic and dias- 
tolic failure, as well as increased LV mass, are asssociated with increased BNP levels. 
Widespread use of BNP after its approved use as a diagnostic aid I” CHF. and as a prog- 
nostic indicator I” acute coronary syndromes, has raised the issue of what other disease 
processes can cause a markedly elevated BNP? 
Methods The BNP Multinational Study was a seven-center prospective study of 1586 
patients presenting to the ED with acute dyspnea and had blinded BNP levels measured 
with a rapid, point-of-care device on arrival. The reference standard for CHF was adjudi- 
cated by two independent cardiologists, also blinded to BNP results. who reviewed all 
clinical data and standardized CHF scores. 
Results: A total of 717 subjects (mean age 57.6 years, 54.3% male) had no history of 
CHF or LV dysfunction and were confirmed by two cardiologist to 9 have CHF. Of 
these, 40/717 (5.6%) and 15fll7 (2.1%) were found to have BNP values 2 500 and 2 
1000 pg/ml, respectively. Of these 40 with BNP 2 500 pglml, 25.0% had a history of 
ischemic heail disease, 12.5% with ischemic changes by electrocardiogram, 42.4% had 
a hlstory of asthma or chonic obstructive pulmonary disease (COPD), and 1 .O% with car 
pulmonale. Physical exam findings included: elevated jugular venous pressure in 15%. 
hepatic congestion in 17.5%. and peripheral edema in 50.0%. Chest x-rays were abnor- 
mal in 52.2% and oxygen saturations were 5 90% in 14.8% of subjects. The most com- 
mon final diagnoses were: asthma or COPD with right ventricular strain, pneumonia, 
pulmonary embolism, anemia, cardiac ischemia, and sepsis. Chronic kidney disease 
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(estimated glomerular filtration rate < 60 mllmin11.73 m2) although not ascribed to be a 
cause of dyspnea, occured in 50.0% of those with elevated BNP values) 500 pg/ml. 
Conclusion: Markedly elevated BNP values in the absense of CHF are rare. When they 
occur, they tend to reflect conditions increasing RV and LV wall tension with superim- 
posed volume overload due to chronic kidney disease. 
500 p.m. 
828FO-5 Myocardial Production of C-Type Natriuretic Peptide in 
Chronic Heart Failure 
Paul Ft. Kalra Jonathan Ft. Clague, Aidan P. Bolger, Philip A. Poole-Wilson, Allan D. 
Struthers, Andrew J. Coats, National Heart Lung Institute, London, United Kingdom, 
Clinical Pharmacology and Therapeutics, Dundee, United Kingdom 
Background: C-type natriuretic peptide (CNP) is a vasodilator produced by the vascular 
endothelium. It shares structural and physiological properties with the cardiac hormones 
atrial and brain natriuretic peptide (BNP). but little is known regarding its pathophysiolog- 
ical role in chronic heart failure (CHF). We assessed the hypothesis that CNP is pro- 
duced by the heart in patients with CHF. 
Methods: Myocardial CNP production was determined (difference in plasma levels 
between the aortic root and coronary sinus) in 9 patients undergoing right and left heart 
catheterisation as part of their CHF assessment (all male, age 59i9y; New York Heart 
Association class 2.2*0.1, LV ejection fraction 29*5%, mean&EM). BNP, established 
as originating from myocardium, was assessed from the same samples as a positive 
control. Analyses were performed using a standard competitive radioimmunoassay kit 
(Peninsula Laboratories, Bachem Ltd. UK). 
Results: A step-up (29%) in plasma CNP concentration was found from the aorta to the 
coronaty sinus (3.55i1.53 versus 4.59il.54 pg/mL, p=O.O35). The mean increase in 
CNP was 0.90+0.35 pg/mL (range 0.05 to 2.60 pg/mL). BNP levels increased by 57% 
from aorta to coronary sinus (66.0+20.5 versus 135.Oi42.2 pg/mL, p=O.Ol). Coronary 
sinus CNP levels correlated with mean pulmonary capillaty wedge pressure (r=O.62, 
p=O.O07). 
Conclusions: We have shown that CNP is produced by the heart in patients with chronic 
heart failure. Whilst fulther evaluation is required to define its full pathophysiological role 
in this condition, CNP may represent an important new local autocrine and/or endocrine 
mediator in the heart. 
5:15 p.m. 
828FO-6 Ventricular Endocrine and Wall Motion Function in 
Acute Myocardial Infarction 
lhab S. Ramzy, Christine A. O’Sullivan, Michael Kemp, James Hooper. Mark C. Dancy, 
Andrew J. Coats, Derek G. Gibson, Michael Y. Henein, Central Middlesex Hospital, 
London, United Kingdom, Royal Brompton Hospital, London, United Kingdom 
Aim: To investigate ventricular endocrine function in patients with coronary artery dis- 
ease during acute myocardial infarction (Ml). 
Methods: We studied 45 patients with acute Ml ; 13 anterior (age 57+ 12 years) and 32 
inferior (age 56+ 12 years). Atrial (ANP) and brain (BNP) natriuretic peptides were mea- 
sured on admission and on day 7 after thrombolysis. No patient was in heart failure, had 
additional valve disease or developed serious arrhythmia during the study period. 
Results: ANP increased from 13.7+ 12.7 on day one to 22.4* 14.0 pmol/L (NS) on day 7 
in anterior MI, and from 5.9* 4.6 to 16.2* 10.6 pmol/L (p<O.OOl) in inferior MI. BNP 
increased from 15.4r 26.1 to 61.7+ 54.3 pmol/L (~~0.02) in anterior Ml and from 6.5+ 
10.3 to 51.4i 52.4 pmollL (p<O.OOl) in Inferior Ml. ANP and BNP levels correlated with 
left free wall long axis excursion in anterior Ml (both r= -0.6, pcO.001). Whereas only BNP 
correlated with the anterior wall excursion in inferior Ml (r= -0.5, p<O.O05). There was no 
significant difference in peak CK level or fractional shortening between the two groups. 
Conclusion: Acute Ml is associated with a delayed rise in ANP and BNP in a pattern 
unrelated to the extent of myocardial damage. This rise is related to the severity of adja- 
cent segmental systolic dysfunction, thus suggesting either a compensatory mechanism 
for the myocardial loss or an ongoing remodeling process. 
ORAL CONTRIBUTIONS 
830 Mechanisms of Vascular Injury and 
Healing 
Monday, March 31,2003, 4:00 p.m.-!%30 p.m. 
McCormick Place, Room S404 
4:oo pm. 
830-1 Genetic Background Is a Major Determinant of 
Arteriogenesis After Femoral Artery Ligation in Inbred 
Mice 
Armin Helisch, Shawn Wagner, Ulrike Brandt, Matthias Heil. Tibor Ziegelhoeffer, Georg 
Bachmann, Wolfgang Schaper, Max-Planck-Institute for Physiol. & Clinical Research, 
Bad Nauheim, Germany. Kerckhoff-Klinik. Bad Nauheim, Germany 
Background: This study was performed to define the differences that may affect the 
recovery of the collateral-dependent hindtimb perfusion after arterial occlusion in inbred 
strains of mice. 
Methods: We ligated the right femoral artery (FA) of C57BU6 (n=l5) and BALB/c (n=l5) 
mice. PerfuSiOn was assessed by laser Doppler imaging (LDI) and calf blood flow by MRI 
(MRflow) on days 0, 3. 7, 14. and 28. MR angiography was performed an the 4” week. 
Furthermore, 8ALBlc and C57BU6 mice (n=5 per group) were fed with BrdU per drinking 
water starting one day prior to right FA ligation. After 7 days the left FA was also ligated 
and the animals were sacrificed. Postmoftem angiograms were performed utilizmg a bis- 
muth-gelatin contrast agent. Arrival of contrast in the left FA distal to the acute ligation 
site was timed and distal fillmg quantified by x-ray. BrdU stained cells were identified on 
cross-sections of adductor muscles. 
Results: BALB/c had more severe ischemia immediately after occlusion and the poorest 
recovery, as reflected by LDI and MR.inflow (p-zO.05, all timepoints). Distal collateral- 
dependent filling on postmortem angiography immediately after FA ligation was observed 
in 414 C57BU6 and O/5 BALBlc mice. Angiographically. similar patterns of preexistent 
and grown collateral vessels were identified in both strains, however, C57 mice tended to 
have better formed interarterial collateral connections in the quadriceps 4 weeks after FA 
ligation. In C57 mice, BrdU uptake during the first week after FA occlusion was seen in all 
layers of growing collateral arterioles and in infiltrating surrounding cells but not in capil- 
laries. Only in BALB/c capillary BrdU uptake was also observed in regions of focal pen- 
necrotic cellular infiltrates. The proliferation Index (BrdU positive cells/total vascular cells) 
in growing arterioles was higher in C57BU6 (0.67) than in BALBic (0.40, p < 0.05). 
Conclusion: Collateral artery growth in mouse hindlimbs of C57BU6 and BALE/c mice 
is independent of capillary proliferation. The improved recovery of C57BLi6 mice is asso- 
ciated with a better preformed collateral network. less acute ischemia, and an increased 
proliferation index in preexistent collateral arterioles. 
4:15 pm. 
830-2 The Early Growth Response-l (EGR-1) Gene Is Critical 
to Reperfusion Following Acute Vascular Obstruction: 
Results From a Knockout Mouse lschemia Model 
Paul Schalcb Ramaswamy Ramchandran, David Y. Kim, Gerald Patejunas, Mauricio A. 
Retuerto. Jeffrey D. Milbrandt, Ronald G. Crystal, Todd K. Rosengart, Evanston 
Northwestern Healthcare Research Institute. Evanston, IL, Weill Medical College of 
Cornell University, New York, NY 
Background: Angiogenesis induced by growth factor upregulation has been implicated as 
an Important biological response mechanism to acute vascular occlusion. The mecha- 
nism underlying this process is unclear, because tissues immediately surrounding vascu- 
lar occlusion sites that are the locus of collateral vessel formation are typically not 
ischemic. The early growth response-l gene (Egr-1) encodes for an immediate-early 
response transcription factor that is upregulated by changes in vascular strain, and which 
in turn upregulates the downstream expression of growth factors such as VEGF. We 
therefore hypothesize that Egr-1 may be an early messenger which translates post-liga- 
tion changes in vascular shear stress into growth factor upregulation and angiogenesis. 
Methods: A hind limb ischemia model consisting of proximal and distal ligation and exci- 
sion of the femoral artery was applied to 2-3 month old wild-type C57 BU6 mice @IO) or 
mice deficient in the Egr-1 gene (“knockout”, w5). Distal hind limb perfusion was serially 
assessed using laser Doppler perfusion imaging and expressed as an index of the mean 
perfusion in the ligated versus the non-ligated limb. 
Results: The pre-ischemic perfusion index for both the Egr-1 knockout and control mice 
was 1.00 * 0.03. Egr-1 knockout mice demonstrated a perfusion index immediately post- 
ligation of 0.15 f 0.02, compared to a post-ligation value of 0.23 * 0.02 in control animals 
(p = 0.006). All Egr-1 knockout mice developed necrosis of the ligated lamb between 1 
and 4 days after the procedure, but none of ,the control animals developed necrosis 
(p=O.OOl). The perfusion index failed to improve in knockout mice, while control mice 
demonstrated significant improvement from baseline in the perfusion Index at day 4 (0.32 
* 0.04, p = 0.01) and day 35 post-ligation (0.77 f 0.02, p=O.OOOl). 
Conclusion: Mice lacking expression of the Egr-1 gene exhibit a profound deficit in vas- 
cular collateralization and reperfusion following acute peripheral arterial occlusion. These 
findings suggest that Egr-1 plays a ptvotal role in vascular recovery in response to acute 
vascular occlusion, and could represent a potential target for therapeuttc intervention. 
4:30 p.m. 
830-3 Constitutive Overexpression of Hypoxia Inducible 
Factor-la/VP-l6 Enhances the In Vitro Angiogenicl 
Arteriogenic Effects of Mesenchymal Stromal Cells 
Tim D. Kinnaird Eugenio Stabile, Mary Susan Burnett, Yi Fu Zhou. Richard B&our. 
Cheol Whan Lee, Shmuel Fuchs, Stephen E. Epstein, Cardiovascular Research Institute, 
Washington, DC 
Background: We have recently demonstrated that mesenchymal stromal cells (MSCs) 
release a broad spectrum of angiogeniciarteriogenic cytokines and augment collateral 
response to ischemia. Constitutive over-expression of the hypoxia inducible factor-la/ 
VP-16 construct I” MSCs may enhance their therapeutic potential. Methods and Results: 
Murine MSCs were purified using double magnetic bead separation of cultured bone 
marrow. Flow cytometry confirmed absence of CD34, CD45, CD31 and CD1 17 surface 
markers, and the presence of SH2 and Sea-1 surface markers. MSCs were replated and 
transduced with Ad.HIF-laNPl6 vector, exposed to normoxia or 1% 02 for 24 hours and 
conditioned media (CM) collected. Using ELISA. CM VEGF and bFGF levels were 
increased following HIF-laNPl6 transduction (fig I); a cytokinelviral dose-dependant 
